Señales en vivo de ISCO | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (26 abr 2024 @ 14:59):

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally...

Stats
Volumen de hoy	525.00
Volumen promedio	1 252.00
Capitalización de mercado	489 869
EPS	$-0.0200 ( 2023-11-13 )
Próxima fecha de ganancias	( $0 ) 2024-06-11
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-3.06
ATR14	$0 (0.00%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-06	Semechkin Andrey	Buy	500 000	Stock Option (Right to Buy)
2023-11-06	Kern Russell	Buy	2 000 000	Stock Option (Right to Buy)
2023-06-14	Don Wright	Buy	445 205	Stock Option (Right to Buy)
2023-06-14	Don Wright	Buy	30 000	Stock Option (Right to Buy)
2023-06-14	Maier Paul V	Buy	445 205	Stock Option (Right to Buy)

INSIDER POWER
100.00
Last 100 transactions
Buy: 8 687 168 \| Sell: 208 326

International Stem Cell Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

International Stem Cell Finanzas

Annual	2023
Ingresos:	$7.79M
Beneficio Bruto:	$4.53M (58.11 %)
EPS:	$-0.0164

FY	2023
Ingresos:	$7.79M
Beneficio Bruto:	$4.53M (58.11 %)
EPS:	$-0.0164

FY	2022
Ingresos:	$8.18M
Beneficio Bruto:	$4.91M (60.04 %)
EPS:	$-0.0582

FY	2021
Ingresos:	$7.18M
Beneficio Bruto:	$4.24M (59.10 %)
EPS:	$-0.110

Financial Reports:

No articles found.

International Stem Cell

International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in North America, Asia, Europe, and internationally. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; and develops, manufactures, and markets anti-aging skincare and human cell culture products. The company's human cell culture products include human skin cells and reagents for the study of skin disease, toxicology, or wound healing; human cells from the heart and blood vessels, and reagents to study cardiovascular disease and cancer; human bronchial and tracheal cell lines for the study of toxicity, cystic fibrosis, asthma, and pathogenesis; and human mammary epithelial cell lines for the study of breast cancer, three dimensional culture, and carcinogen screening. Its human cell culture products also comprise adult stem cells and reagents for regenerative medicine; human prostate cells and specialized medium to study prostate disease; human renal and bladder cells and media to study renal and bladder diseases; human corneal cells and media for the study of corneal disease; human female reproductive system cells for the study of cellular physiology; human skeletal muscle cells for the study of biology, diabetes, insulin receptor studies, muscle metabolism, muscle tissue repair, and myotube development; and other cell culture reagents and supplements for the growth, staining, and freezing of human cells. The company sells skincare products through a website and professional channels; and human cell culture products through its sales force, OEM partners, and brand distributors. International Stem Cell Corporation was founded in 2001 and is headquartered in San Diego, California.